Hydrodissection and hydrodilatation for joint pain: a scoping review Authors: Benjamin Leahy, Harry McGrath, Dominic Harmon Published: 2026 ABSTRACT ObjectiveTo evaluate the current evidence regarding the effectiveness and safety of ultrasound-guided hydrodissection (US-HD) in the management of joint-related pain.MethodsA systematic search of PubMed, Embase, Cochrane Library, and Google Scholar was conducted for studies published in the past 15 years. Eligible studies included randomised controlled trials (RCTs), cohort studies, and case series investigating hydrodissection for joint pain (e.g., shoulder, hip, knee, sacroiliac joint). Outcomes included pain reduction, functional improvement, and complication rates. Data extraction and qualitative synthesis were performed due to heterogeneity in study design and outcome measures.ResultsA total of 138 studies were identified, of which 21 met inclusion criteria. Evidence suggests that US-HD may provide significant pain relief and functional improvement in conditions such as adhesive capsulitis, greater trochanteric pain syndrome, and knee osteoarthritis. Studies consistently reported low complication rates. However, heterogeneity in technique, injectate composition, and outcome measures was noted.ConclusionUltrasound-guided hydrodissection appears to be a safe and promising intervention for joint-related pain. While early evidence is encouraging, larger high-quality trials are required to establish standardised protocols and confirm long-term efficacy. Introduction Joint-region pain is increasingly understood as a multifactorial phenomenon extending beyond isolated intra-articular pathology, supporting broader treatment approaches such as hydrodissection. Intra-articular contributors—including osteoarthritis, synovitis, labral or meniscal injury, and effusion—are common but demonstrate a poor correlation between structural abnormalities and pain severity, with similar imaging findings frequently observed in asymptomatic individuals. Peri-articular structures play a significant role, with tendinopathy, bursitis, ligamentous dysfunction, and myofascial pain often acting as primary pain generators; notably, tendinopathy along a reactive–degenerative continuum is a key driver of persistent symptoms and responds more effectively to load-based and targeted interventions than passive treatments. Neural mechanisms further contribute, including peripheral sensitisation, nerve entrapment, radicular pain, and central sensitisation, the latter characterised by disproportionate pain, allodynia, and symptom spread independent of local tissue damage. Systemic inflammatory conditions, such as rheumatoid arthritis, seronegative spondyloarthropathies, and crystal arthropathies, contribute via cytokine-mediated pathways that amplify both local and central pain processes. Additionally, psychosocial factors—including fear avoidance, catastrophising, sleep disturbance, and mood disorders—are strong predictors of pain chronicity, disability, and treatment outcomes. Collectively, this multidimensional model underscores the limitations of purely intra-articular interventions and supports more comprehensive, mechanism-based management strategies. Hydrodissection is a minimally invasive interventional technique that involves the targeted injection of fluid to separate tissue planes under imaging guidance. Initially described in the context of peripheral nerve entrapment syndromes, its application has expanded into musculoskeletal medicine, particularly in the management of joint and periarticular pain. The theoretical basis of hydrodissection in joint pathology lies in its ability to disrupt adhesions, restore normal tissue gliding, and reduce mechanical and inflammatory contributors to pain. Joint pain is a highly prevalent clinical problem, contributing significantly to disability and reduced quality of life worldwide. Conditions such as adhesive capsulitis of the shoulder, osteoarthritis of the knee, and periarticular syndromes including greater trochanteric pain syndrome are commonly encountered in both primary care and specialist settings. Traditional management strategies include pharmacological therapy, physiotherapy, corticosteroid injections, and surgical intervention in refractory cases. However, these approaches may provide limited or temporary relief, and are often associated with side effects or procedural risks. Corticosteroid injections are currently the predominant treatment strategy. Corticosteroid injection, while effective for short-term symptom relief, has well-documented deleterious effects on tendon structure and function, which provides a rationale for alternative approaches such as hydrodissection. Steroids impair tendon integrity by reducing type I collagen synthesis and increasing collagen degradation, resulting in a weaker and more disorganized extracellular matrix. They also inhibit tenocyte proliferation and promote apoptosis, thereby disrupting normal tissue repair and regeneration. These cellular and structural changes translate into reduced mechanical properties, with tendons demonstrating decreased stiffness and tensile strength following exposure. Clinically, this is associated with an increased risk of tendon rupture—most notably in the Achilles, rotator cuff, and patellar tendons—particularly with repeated or intratendinous injections. Furthermore, corticosteroids suppress the early inflammatory phase of healing, leading to delayed recovery and inferior repair tissue. Prolonged exposure may also accelerate matrix degeneration, contributing to progression of tendinopathy and transformation from a reactive to a degenerative state. Hydrodissection offers a potential alternative that combines both mechanical and pharmacological mechanisms. By injecting fluid into the pericapsular or periarticular space, the technique aims to physically separate fibrotic or inflamed tissues, reduce nociceptive signalling, and improve joint mobility. The addition of agents such as dextrose, local anaesthetic, corticosteroids, or platelet-rich plasma (PRP) may further enhance therapeutic outcomes through anti-inflammatory or regenerative effects. Ultrasound guidance has played a critical role in the evolution of hydrodissection, enabling real-time visualization of anatomical structures, accurate needle placement, and confirmation of injectate spread. This has improved both the safety and efficacy of the technique, making it increasingly accessible in outpatient settings. Despite growing clinical interest, the evidence base for hydrodissection in joint pain remains fragmented. Studies vary widely in terms of target pathology, procedural technique, injectate composition, and outcome measures. This heterogeneity poses challenges for interpretation and limits the ability to draw firm conclusions regarding its clinical utility. This scoping review aims to synthesise the current literature on ultrasound-guided hydrodissection for joint-related pain, with a focus on effectiveness, safety, and technical considerations. By consolidating available evidence, we aim to provide a clearer understanding of its role within contemporary pain management strategies. Objectives To evaluate the effectiveness of ultrasound-guided hydrodissection in joint-related pain conditions To evaluate the effectiveness of ultrasound-guided hydrodissection in joint-related pain conditions To assess safety outcomes and complication rates To assess safety outcomes and complication rates To summarise current procedural techniques and evaluate current procedural characteristics of US-HD in joint-related pain To summarise current procedural techniques and evaluate current procedural characteristics of US-HD in joint-related pain Methods Search strategy A structured literature search was conducted using PubMed, Embase, Cochrane Library, and Google Scholar. The search strategy incorporated combinations of Medical Subject Headings (MeSH) and free-text terms. Key search terms included: “hydrodissection” AND “joint pain”“ultrasound-guided hydrodissection” AND (“shoulder” OR “hip” OR “knee” OR “sacroiliac”)“adhesive capsulitis” OR “capsular distension” AND “hydrodissection”Boolean operators were used to refine search results. Searches were limited to studies published between January 2010 and March 2025 and restricted to English-language publications. One PubMed search string has been included in Supplementary Material 1 section. “hydrodissection” AND “joint pain” “hydrodissection” AND “joint pain” “ultrasound-guided hydrodissection” AND (“shoulder” OR “hip” OR “knee” OR “sacroiliac”) “ultrasound-guided hydrodissection” AND (“shoulder” OR “hip” OR “knee” OR “sacroiliac”) “adhesive capsulitis” OR “capsular distension” AND “hydrodissection” “adhesive capsulitis” OR “capsular distension” AND “hydrodissection” Study selection Titles and abstracts were screened independently to identify potentially eligible studies. Fulltext articles were then reviewed against predefined inclusion and exclusion criteria. Disagreements were resolved through discussion. Inclusion criteria Adult patients (≥18 years) with joint-related or periarticular pain Adult patients (≥18 years) with joint-related or periarticular pain Intervention involving ultrasound-guided hydrodissection Intervention involving ultrasound-guided hydrodissection Reported outcomes including pain scores, functional measures, or safety data Reported outcomes including pain scores, functional measures, or safety data Study designs including RCTs, prospective or retrospective cohort studies, and case series Study designs including RCTs, prospective or retrospective cohort studies, and case series Exclusion criteria Non-ultrasound-guided procedures Non-ultrasound-guided procedures Intra-articular injections without a hydrodissection component Intra-articular injections without a hydrodissection component Animal or paediatric studies Animal or paediatric studies Narrative reviews, editorials, and duplicate publications Narrative reviews, editorials, and duplicate publications Data extraction and synthesis Data extracted included study design, sample size, patient population, target joint, procedural technique, injectate type and volume, outcomes, and complications. Due to methodological heterogeneity, a meta-analysis was not feasible, and a qualitative synthesis was performed. PRISMA framework The study selection process followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A flow diagram illustrating study identification, screening, eligibility, and inclusion is described (Figure 1). Figure 1PRISMA Flow Diagram.Flowchart showing a systematic review process: 138 records identified, 112 remain after duplicates removed. After exclusions, 38 reports retrieved and assessed; 21 studies included in the final review. Key exclusion criteria and numbers are listed in blue boxes. PRISMA Flow Diagram. Results Study characteristics A total of 138 records were identified. Following screening and eligibility assessment, 21 studies were included. These comprised: 3 randomised controlled trials1 pilot randomised trial3 cohort studies1 retrospective study9 case reports3 case series1 case report and reviewAbove is a table detailing the risk of bias assessment for the studies included. 3 randomised controlled trials 3 randomised controlled trials 1 pilot randomised trial 1 pilot randomised trial 3 cohort studies 3 cohort studies 1 retrospective study 1 retrospective study 9 case reports 9 case reports 3 case series 3 case series 1 case report and review 1 case report and review The overall evidence base is therefore low quality and at high risk of bias (Figure 2, Table 1). Figure 2Traffic-light summary of the overall methodological quality and risk of bias of included studies. Each point represents the overall assessment for an individual study following appraisal with the RoB 2, Newcastle–Ottawa Scale, or Joanna Briggs Institute critical appraisal tools, as appropriate. Table 1Assessment of study quality.No.Study (Author, Year)Study designAppraisal toolQuality/RoB assessment1Hsu et al. 2024 (1)RCTRoB2Some concerns–High risk2Omodani 2024 (2)Case reportJBIVery low quality3Vita et al. 2024 (3)Prospective study (no control)NOSModerate quality (5/9)4Sullivan et al. 2025 (4)Case reportJBIVery low quality5Chavez-Chiang et al. 2012 (5)Cohort studyNOSGood quality (7/9)6Dosal et al. 2023 (6)Case seriesJBIVery low quality7Eliot Hu et al. 2022 (7)Case reportJBIVery low quality8Skinner 2017 (8)Narrative/case-basedNot applicableVery low quality9Omodani & Takahashi 2023 (9)Case reportJBIVery low quality10Yoshinaga et al. 2025 (10)Case reportJBIVery low quality11Go et al. 2022 (11)Case reportJBIVery low quality12Burke et al. 2019 (12)Case seriesJBIVery low quality13Chen et al. 2025 (13)Retrospective cohortNOSModerate quality (5/9)14Marrero Borrero et al. 2026 (14)Case reportJBIVery low quality15Rogers et al. 2012 (15)Case reportJBIVery low quality16Koonen et al. 2023 (16)Pilot RCTRoB 2High risk17Liao et al. 2025 (17)Prospective study (no control)NOS (limited applicability)Low quality18Saito et al. 2025 (18)Case series (n = 2)JBIVery low quality19Naoi et al. 2025 (19)Case reportJBIVery low quality20Lin et al. 2020 (20)Double-blind RCTRoB 2Low risk21Dougherty et al. 2025 (21)Case reportJBIVery low quality Traffic-light summary of the overall methodological quality and risk of bias of included studies. Each point represents the overall assessment for an individual study following appraisal with the RoB 2, Newcastle–Ottawa Scale, or Joanna Briggs Institute critical appraisal tools, as appropriate. Table 1Assessment of study quality.No.Study (Author, Year)Study designAppraisal toolQuality/RoB assessment1Hsu et al. 2024 (1)RCTRoB2Some concerns–High risk2Omodani 2024 (2)Case reportJBIVery low quality3Vita et al. 2024 (3)Prospective study (no control)NOSModerate quality (5/9)4Sullivan et al. 2025 (4)Case reportJBIVery low quality5Chavez-Chiang et al. 2012 (5)Cohort studyNOSGood quality (7/9)6Dosal et al. 2023 (6)Case seriesJBIVery low quality7Eliot Hu et al. 2022 (7)Case reportJBIVery low quality8Skinner 2017 (8)Narrative/case-basedNot applicableVery low quality9Omodani & Takahashi 2023 (9)Case reportJBIVery low quality10Yoshinaga et al. 2025 (10)Case reportJBIVery low quality11Go et al. 2022 (11)Case reportJBIVery low quality12Burke et al. 2019 (12)Case seriesJBIVery low quality13Chen et al. 2025 (13)Retrospective cohortNOSModerate quality (5/9)14Marrero Borrero et al. 2026 (14)Case reportJBIVery low quality15Rogers et al. 2012 (15)Case reportJBIVery low quality16Koonen et al. 2023 (16)Pilot RCTRoB 2High risk17Liao et al. 2025 (17)Prospective study (no control)NOS (limited applicability)Low quality18Saito et al. 2025 (18)Case series (n = 2)JBIVery low quality19Naoi et al. 2025 (19)Case reportJBIVery low quality20Lin et al. 2020 (20)Double-blind RCTRoB 2Low risk21Dougherty et al. 2025 (21)Case reportJBIVery low quality Assessment of study quality. Effectiveness Adhesive capsulitis (frozen shoulder) Adhesive capsulitis was the most extensively studied indication for hydrodissection. Several randomised controlled trials demonstrated significant improvements in pain scores and shoulder range of motion following capsular hydrodissection. These benefits were often observed within weeks of the procedure and were sustained for up to six months in some studies. Hydrodissection in this context typically involved capsular distension with relatively large volumes (20–40 mL) of saline, often combined with corticosteroid and local anaesthetic. The mechanical expansion of the joint capsule is thought to disrupt adhesions and improve capsular compliance. Comparative studies suggested that hydrodissection may provide superior short-term functional improvement compared to intra-articular steroid injection alone. However, longterm outcomes were less consistently reported. Knee osteoarthritis Evidence for hydrodissection in knee osteoarthritis is more limited but suggests potential benefit. Studies focusing on periarticular hydrodissection, rather than purely intra-articular injection, reported modest reductions in pain and improvements in function. Target structures included the suprapatellar pouch, medial retinaculum, and peri-tendinous tissues. The mechanism in osteoarthritis is likely multifactorial, involving reduction of soft tissue tension, improved synovial fluid distribution, and possible neuromodulation. Greater trochanteric pain syndrome (GTPS) Several case series reported positive outcomes following hydrodissection of the gluteal tendons and iliotibial band in patients with GTPS. Patients experienced reductions in lateral hip pain and improvements in mobility. Although encouraging, these findings are limited by the absence of control groups and small sample sizes. Other joint applications Emerging evidence suggests potential roles for hydrodissection in sacroiliac joint dysfunction and hip impingement syndromes. However, these applications remain under-investigated, and current data are insufficient to draw firm conclusions. Overall, hydrodissection appears most effective in conditions characterised by fibrosis, adhesions, or restricted tissue mobility. Overall Clinical outcomes across the included studies consistently demonstrated meaningful reductions in pain following ultrasound-guided hydrodissection. Pain was most commonly measured using the Visual Analogue Scale (VAS) or Numerical Rating Scale (NRS/NPRS). Among studies reporting quantitative outcomes, pain reductions ranged from approximately 3 to 6 points on a 10-point scale. For example, Hsu et al. reported a reduction in VAS scores from 3.7 to 1.4 in patients with myofascial pain syndrome, while Vita et al. demonstrated improvement from 7.65 to 1.65 in De Quervain's tenosynovitis. Sullivan et al. observed a decrease from 8 to 3 in patients with adhesive capsulitis and osteoarthritis, and Liao et al. reported improvement from 7 to 2. Similar benefits were observed in neuropathic, tendinopathic, and post-surgical pain conditions. Functional outcomes were reported using a variety of validated instruments, including the Disabilities of the Arm, Shoulder and Hand (DASH) score, Shoulder and Neck Disability Index, and condition-specific functional assessments. Across studies, improvements were observed in upper and lower limb function, return to sport, walking tolerance, grip strength, and activities of daily living. A table with a summary of this data is available in Supplementary Material 3 and a table containing information about the four main pathologies are available in Supplementary Material 4. Safety and complications Across all included studies, ultrasound-guided hydrodissection demonstrated a favourable safety profile. No major complications such as infection, neurovascular injury, or permanent disability were reported. Minor and transient adverse effects included: Localised pain or discomfort at the injection siteTemporary stiffness or swellingMild vasovagal reactionsThe use of ultrasound guidance was consistently emphasised as a key factor in minimising procedural risk. Real-time visualisation allows avoidance of critical structures and ensures accurate delivery of injectate. Localised pain or discomfort at the injection site Localised pain or discomfort at the injection site Temporary stiffness or swelling Temporary stiffness or swelling Mild vasovagal reactions Mild vasovagal reactions The outpatient nature of the procedure, absence of general anaesthesia, and rapid recovery further contribute to its safety and acceptability. Technique and injectates Significant variability was observed in procedural techniques across studies. Needle approach Both in-plane and out-of-plane approaches were described. The in-plane technique allows continuous visualisation of the needle shaft and tip, improving precision and safety. Target structures Shoulder: Glenohumeral capsule, rotator interval Shoulder: Glenohumeral capsule, rotator interval Knee: Periarticular soft tissues, suprapatellar pouch Knee: Periarticular soft tissues, suprapatellar pouch Hip: Gluteal tendons, iliotibial band Hip: Gluteal tendons, iliotibial band Injectates Commonly used injectates included: Normal saline5% dextrose solutionLocal anaesthetics (e.g., lidocaine)CorticosteroidsPlatelet-rich plasma (PRP)Dextrose has been proposed to have neuromodulatory effects, while PRP may contribute to tissue healing. Normal saline Normal saline 5% dextrose solution 5% dextrose solution Local anaesthetics (e.g., lidocaine) Local anaesthetics (e.g., lidocaine) Corticosteroids Corticosteroids Platelet-rich plasma (PRP) Platelet-rich plasma (PRP) Volume of injection Volumes varied widely, ranging from 5 mL in small peri-tendinous spaces to over 40 mL in capsular distension procedures. Despite these differences, core principles remained consistent: precise needle placement, slow injectate delivery, and visualization of tissue separation. Discussion This scoping review highlights ultrasound-guided hydrodissection as a promising and evolving intervention in the management of joint-related pain. The technique offers a unique combination of mechanical and pharmacological effects, distinguishing it from conventional injection therapies. The strongest evidence exists for adhesive capsulitis, where hydrodissection appears to improve both pain and function. The mechanical disruption of capsular adhesions is likely a key mechanism, supported by the consistent use of high-volume injectates in these studies. In knee osteoarthritis and periarticular syndromes, the benefits of hydrodissection may be more modest but still clinically meaningful. The ability to target soft tissue structures rather than solely intra-articular pathology represents an important advantage. Treating both pathologies of intraarticular pathology and soft tissue structures simultaneously is a likely advantage. These concurrent pathologies are common in joint pain. Safety outcomes are consistently favourable, reinforcing the role of ultrasound guidance in modern interventional practice. The low complication rate compares favourably with other invasive procedures, including surgical interventions. However, several limitations must be considered. The heterogeneity of study designs, techniques, and outcome measures limits comparability. Many studies are small and lack control groups, increasing the risk of bias. Additionally, follow-up periods are often short, making it difficult to assess long-term efficacy. There is also a lack of consensus regarding optimal technique, including injectate type, volume, and frequency of treatment. Standardisation will be essential for future research and clinical implementation. Limitations Heterogeneity in study design and methodology Heterogeneity in study design and methodology Small sample sizes in many included studies Small sample sizes in many included studies Predominance of low-level evidence Predominance of low-level evidence Lack of high-quality comparative studies Lack of high-quality comparative studies Limited long-term follow-up Limited long-term follow-up Potential publication bias Potential publication bias Lack of standardized procedural protocols Lack of standardized procedural protocols Concurrent treatments (e.g., corticosteroids, physiotherapy) were frequently used Concurrent treatments (e.g., corticosteroids, physiotherapy) were frequently used Conclusion Ultrasound-guided hydrodissection may be a safe intervention based on limited observational data. There is currently insufficient high-quality evidence to support its effectiveness for joint-related pain. It shows particular promise in adhesive capsulitis and periarticular syndromes, where mechanical factors play a significant role in symptom generation. While early results are encouraging, the current evidence base remains limited. High-quality randomised controlled trials are needed to establish efficacy, optimise techniques, and define its role within clinical practice. Future directions Future research should focus on: Standardisation of technique and injectate protocolsLarge-scale randomised controlled trialsComparative studies vs. corticosteroid injection and physiotherapyLong-term outcome assessmentCost-effectiveness analyse Standardisation of technique and injectate protocols Standardisation of technique and injectate protocols Large-scale randomised controlled trials Large-scale randomised controlled trials Comparative studies vs. corticosteroid injection and physiotherapy Comparative studies vs. corticosteroid injection and physiotherapy Long-term outcome assessment Long-term outcome assessment Cost-effectiveness analyse Cost-effectiveness analyse